89bio, Inc. (ETNB)
NASDAQ
Market Cap
$719.19M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
21 of 809
Rank in Industry
18 of 445
Largest Insider Buys in Sector
ETNB Stock Price History Chart
ETNB Stock Performance
About 89bio, Inc.
89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop pegozafermin for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.
Insider Activity of 89bio, Inc.
Over the last 12 months, insiders at 89bio, Inc. have bought $20.72M and sold $1.42M worth of 89bio, Inc. stock.
On average, over the past 5 years, insiders at 89bio, Inc. have bought $61.99M and sold $5.61M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $518.06M.
The last purchase of 1,350,000 shares for transaction amount of $20.72M was made by RA CAPITAL MANAGEMENT, L.P. () on 2024‑03‑04.
List of Insider Buy and Sell Transactions, 89bio, Inc.
| 2024-04-01 | Sale | PALEKAR ROHAN | Chief Executive Officer | 52,718 0.0573% | $10.91 | $575,153 | -17.43% | |
| 2024-03-04 | RA CAPITAL MANAGEMENT, L.P. | 1.35M 1.6718% | $15.35 | $20.72M | -34.00% | |||
| 2024-02-26 | Sale | PALEKAR ROHAN | Chief Executive Officer | 4,477 0.0047% | $10.76 | $48,173 | -16.77% | |
| 2023-12-29 | Sale | PALEKAR ROHAN | Chief Executive Officer | 50,000 0.0549% | $11.20 | $560,000 | -12.48% | |
| 2023-07-17 | Sale | LAPORTE KATHLEEN | director | 12,500 0.024% | $18.80 | $235,000 | -42.94% | |
| 2023-06-05 | Sale | PALEKAR ROHAN | Chief Executive Officer | 15,000 0.0282% | $20.00 | $300,000 | -44.75% | |
| 2023-06-01 | Sale | Atkinson Edward Morrow III | director | 6,250 0.0112% | $17.91 | $111,938 | -41.25% | |
| 2023-05-09 | Sale | Le-Nguyen Quoc | See Remarks | 13,683 0.0258% | $18.11 | $247,799 | -36.64% | |
| 2023-04-04 | Sale | Martins Ryan | Chief Financial Officer | 8,721 0.0165% | $14.95 | $130,379 | -2.87% | |
| 2023-03-28 | Hayden Michael R | director | 61,538 0.112% | $16.15 | $993,839 | -11.14% | ||
| 2023-03-24 | RA CAPITAL MANAGEMENT, L.P. | 2.46M 4.6238% | $16.25 | $40M | -7.38% | |||
| 2023-03-23 | Sale | PALEKAR ROHAN | Chief Executive Officer | 15,000 0.0266% | $16.00 | $240,000 | -10.98% | |
| 2023-03-23 | Sale | Martins Ryan | Chief Financial Officer | 5,000 0.0089% | $16.11 | $80,550 | -10.98% | |
| 2023-03-01 | Sale | Atkinson Edward Morrow III | director | 10,000 0.0184% | $13.60 | $136,000 | +8.33% | |
| 2023-02-21 | Sale | Martins Ryan | Chief Financial Officer | 2,540 0.0048% | $13.89 | $35,281 | +8.71% | |
| 2023-02-08 | Sale | Martins Ryan | Chief Financial Officer | 1,480 0.0027% | $14.41 | $21,327 | +3.28% | |
| 2023-02-03 | Sale | Martins Ryan | Chief Financial Officer | 3,592 0.0067% | $13.04 | $46,848 | +14.12% | |
| 2023-01-03 | Sale | Martins Ryan | Chief Financial Officer | 5,947 0.0117% | $12.51 | $74,397 | +26.15% | |
| 2022-10-18 | RA CAPITAL MANAGEMENT, L.P. | director | 1.17M 2.9627% | $7.65 | $8.97M | +74.54% | ||
| 2022-07-01 | Shah Rajeev M. | 2.82M 6.5316% | $3.55 | $10M | +239.97% |
Insider Historical Profitability
35.01%
| RA CAPITAL MANAGEMENT, L.P. | 12431584 12.2079% | $7.31 | 10 | 0 | <0.0001% | |
| PALEKAR ROHAN | Chief Executive Officer | 459171 0.3318% | $7.31 | 4 | 5 | <0.0001% |
| LAPORTE KATHLEEN | director | 0 0% | $7.31 | 0 | 1 | |
| Shah Rajeev M. | 7782669 8.5737% | $7.31 | 1 | 0 | +239.97% | |
| Longitude Capital Partners III, LLC | 10 percent owner | 2600877 2.8652% | $7.31 | 2 | 0 | +2.62% |
| Naschitz Anat | 1864721 2.0543% | $7.31 | 1 | 1 | +28.8% | |
| ORBIMED ADVISORS LLC | 10 percent owner | 1829433 2.0154% | $7.31 | 1 | 3 | +28.8% |
| Kariv Tomer | 250000 0.2754% | $7.31 | 1 | 0 | +28.8% | |
| Le-Nguyen Quoc | See Remarks | 164971 0.1817% | $7.31 | 0 | 2 | |
| Hayden Michael R | director | 61538 0.0678% | $7.31 | 8 | 0 | +100.2% |
| Martins Ryan | Chief Financial Officer | 53578 0.059% | $7.31 | 0 | 7 | |
| Waisbourd Ram | See Remarks | 0 0% | $7.31 | 0 | 15 | |
| Grunberg Gregory | director | 0 0% | $7.31 | 2 | 1 | +2.62% |
| Atkinson Edward Morrow III | director | 0 0% | $7.31 | 0 | 2 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| RA Capital Management, L.P. | $148.61M | 12.98 | 12.77M | +11.82% | +$15.71M | 0.15 | |
| Janus Henderson | $146.65M | 12.81 | 12.6M | +41.37% | +$42.91M | 0.08 | |
| RTW Investments, LP | $85.89M | 7.5 | 7.38M | +32.26% | +$20.95M | 1.27 | |
| BlackRock | $77.27M | 6.75 | 6.64M | +21.7% | +$13.78M | <0.01 | |
| Suvretta Capital Management, LLC | $73.31M | 6.4 | 6.3M | +28.84% | +$16.41M | 3.09 | |
| State Street | $64.53M | 5.64 | 5.54M | +2.67% | +$1.68M | <0.01 | |
| The Vanguard Group | $54.98M | 4.8 | 4.72M | +9.64% | +$4.84M | <0.01 | |
| Bvf Inc Il | $47.11M | 4.11 | 4.05M | 0% | +$0 | 0.35 | |
| Holocene Advisors, LP | $40.17M | 3.51 | 3.45M | -1.14% | -$464,889.96 | 0.15 | |
| Laurion Capital Management LP | $31.42M | 2.74 | 2.7M | -0.17% | -$55,080.48 | 0.88 | |
| Redmile Group | $26.36M | 2.3 | 2.26M | +14.99% | +$3.44M | 0.98 | |
| Westfield Capital Management Co Lp | $25.19M | 2.2 | 2.16M | +22.88% | +$4.69M | 0.13 | |
| Geode Capital Management | $20.27M | 1.77 | 1.74M | +26.36% | +$4.23M | <0.01 | |
| Citadel Advisors LLC | $18.27M | 1.6 | 1.57M | -27.95% | -$7.09M | 0.01 | |
| Millennium Management LLC | $12.65M | 1.11 | 1.09M | +94.53% | +$6.15M | 0.01 | |
| Frazier Life Sciences Management L P | $11.64M | 1.02 | 1M | -50% | -$11.64M | 0.6 | |
| Bioimpact Capital Llc | $11.26M | 0.98 | 967,742 | New | +$11.26M | 1.82 | |
| Franklin Templeton Investments | $9.63M | 0.84 | 827,657 | <0.01% | -$535.44 | <0.01 | |
| Morgan Stanley | $9.46M | 0.83 | 812,622 | -45.44% | -$7.88M | <0.01 | |
| Orchard Capital Managment Llc | $8.72M | 0.76 | 749,350 | +1.37% | +$118,052.88 | 2.56 | |
| Goldman Sachs | $8.67M | 0.76 | 744,948 | +18.04% | +$1.33M | <0.01 | |
| Northern Trust | $8.32M | 0.73 | 714,531 | +15.62% | +$1.12M | <0.01 | |
| HERITAGE ASSET MANAGEMENT INC | $7.29M | 0.69 | 679,767 | -3.18% | -$239,579.41 | 0.04 | |
| Charles Schwab | $7.32M | 0.64 | 629,233 | +26.01% | +$1.51M | <0.01 | |
| Nuveen | $6.41M | 0.56 | 550,594 | +127.15% | +$3.59M | <0.01 | |
| Sphera Fund | $6M | 0.52 | 515,882 | +26.23% | +$1.25M | 0.99 | |
| Standard Life | $5.48M | 0.48 | 470,387 | +119.61% | +$2.98M | 0.01 | |
| Rafferty Asset Management Llc | $5.38M | 0.47 | 461,952 | +1.82% | +$96,355.91 | 0.02 | |
| Adage Capital Partners Gp L L C | $5.24M | 0.46 | 450,000 | -85.6% | -$31.14M | 0.01 | |
| Citigroup | $4.87M | 0.43 | 418,259 | +94.9% | +$2.37M | <0.01 | |
| Bank of America | $4.76M | 0.42 | 408,639 | +50.29% | +$1.59M | <0.0001 | |
| Barclays | $4.12M | 0.36 | 354,088 | -34.86% | -$2.21M | <0.01 | |
| UBS | $3.73M | 0.33 | 320,732 | +12.74% | +$421,775.35 | <0.01 | |
| Candriam S C A | $3.61M | 0.32 | 310,000 | +10.71% | +$349,200.00 | 0.02 | |
| Wellington Management Company | $3.58M | 0.31 | 307,924 | +28.82% | +$801,961.22 | <0.01 | |
| Integral Health Asset Management Llc | $3.49M | 0.31 | 300,000 | New | +$3.49M | 0.35 | |
| Alyeska Investment Group L P | $3.49M | 0.31 | 300,000 | -48.56% | -$3.3M | 0.02 | |
| Newtyn Management | $2.91M | 0.25 | 250,000 | -8.26% | -$261,900.00 | 0.63 | |
| BNY Mellon | $2.9M | 0.25 | 248,746 | +11.84% | +$306,434.59 | <0.01 | |
| Two Sigma | $2.86M | 0.25 | 246,100 | +91.13% | +$1.37M | 0.01 | |
| AllianceBernstein | $2.69M | 0.24 | 231,007 | -22.74% | -$791,310.34 | <0.01 | |
| Susquehanna International Group | $2.09M | 0.18 | 179,962 | +8.27% | +$160,073.30 | <0.01 | |
| Parkman Healthcare Partners Llc | $2.09M | 0.18 | 179,899 | -18.02% | -$460,350.28 | 0.26 | |
| Comerica | $1.99M | 0.17 | 171,000 | +9.66% | +$175,414.80 | 0.01 | |
| Swiss National Bank | $1.71M | 0.15 | 147,200 | +3.08% | +$51,216.00 | <0.01 | |
| Two Sigma Advisers LP | $1.67M | 0.15 | 143,500 | -14.23% | -$277,032.00 | <0.01 | |
| Caption Management Llc | $1.64M | 0.14 | 140,984 | -45.77% | -$1.39M | 0.05 | |
| Raymond James Associates | $1.57M | 0.14 | 135,273 | +24.79% | +$312,766.86 | <0.01 | |
| Schonfeld Group | $1.56M | 0.14 | 134,054 | +72.4% | +$655,285.20 | 0.01 | |
| Royal Bank of Canada | $1.53M | 0.13 | 130,996 | -47.38% | -$1.37M | <0.0001 |